KMT2A and acute lymphoblastic leukemia: Among the most effective drugs we found vincristine, cytarabine and vorinostat, which either are already being used in current treatment protocols or have been identified previously as therapeutic options for MLL-rearranged ALL, confirming the validity of our screening approach.